|
Q2 FY2027
As of Sep 30, 2026
|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Investments at fair value | |||||||||||||||||
| Non-control/Non-affiliate investments | |||||||||||||||||
| Affiliate investments | |||||||||||||||||
| Control investments | |||||||||||||||||
| Total investments at fair value | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Restricted cash | |||||||||||||||||
| Receivables: | |||||||||||||||||
| Dividends and interest | |||||||||||||||||
| Escrow | |||||||||||||||||
| Other | |||||||||||||||||
| Income tax receivable | |||||||||||||||||
| Debt issuance costs (net of accumulated amortization of $15,637 and $13,172, respectively) | |||||||||||||||||
| Other assets | |||||||||||||||||
| Total assets | |||||||||||||||||
| Liabilities | |||||||||||||||||
| SBA Debentures (net of $7,336 and $5,333, respectively, of unamortized debt issuance costs) | |||||||||||||||||
| Notes | |||||||||||||||||
| January 2026 Notes | |||||||||||||||||
| October 2026 Notes | |||||||||||||||||
| August 2028 Notes | |||||||||||||||||
| 2029 Convertible Notes | |||||||||||||||||
| September 2030 Notes | |||||||||||||||||
| September 2031 Notes | |||||||||||||||||
| Credit Facilities | |||||||||||||||||
| Other liabilities | |||||||||||||||||
| Accrued restoration plan liability | |||||||||||||||||
| Income tax payable | |||||||||||||||||
| Deferred tax liability | |||||||||||||||||
| Total liabilities | |||||||||||||||||
| Net Assets | |||||||||||||||||
| Common stock, $0.25 par value: authorized, 135,000,000 shares at September 30, 2026 and 75,000,000 shares at March 31, 2026; issued, 66,491,300 shares at September 30, 2026 and 60,577,181 shares at March 31, 2026 | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Total distributable (loss) earnings | |||||||||||||||||
| Treasury stock - at cost, no shares at March 31, 2024 and 2,339,512 shares at March 31, 2023 | |||||||||||||||||
| Total net assets | |||||||||||||||||
| Total liabilities and net assets | |||||||||||||||||
| Net asset value per share (in usd per share) | |||||||||||||||||
Loading...